

[ Mon, May 04th 2020
] - WOPRAI
[ Mon, May 04th 2020
] - WOPRAI
[ Mon, May 04th 2020
] - WOPRAI
[ Mon, May 04th 2020
] - WOPRAI
[ Mon, May 04th 2020
] - WOPRAI
[ Mon, May 04th 2020
] - WOPRAI
[ Mon, May 04th 2020
] - WOPRAI
[ Mon, May 04th 2020
] - WOPRAI
[ Mon, May 04th 2020
] - WOPRAI
[ Mon, May 04th 2020
] - WOPRAI
[ Mon, May 04th 2020
] - WOPRAI
[ Mon, May 04th 2020
] - WOPRAI
[ Mon, May 04th 2020
] - WOPRAI
[ Mon, May 04th 2020
] - WOPRAI
[ Mon, May 04th 2020
] - WOPRAI
[ Mon, May 04th 2020
] - WOPRAI
[ Mon, May 04th 2020
] - WOPRAI
[ Mon, May 04th 2020
] - WOPRAI
[ Mon, May 04th 2020
] - WOPRAI
[ Mon, May 04th 2020
] - WOPRAI
[ Mon, May 04th 2020
] - WOPRAI
[ Mon, May 04th 2020
] - WOPRAI
[ Mon, May 04th 2020
] - WOPRAI
[ Mon, May 04th 2020
] - WOPRAI
[ Mon, May 04th 2020
] - WOPRAI
[ Mon, May 04th 2020
] - WOPRAI
[ Mon, May 04th 2020
] - WOPRAI
David Amsellem Maintained (AVDL) at Buy with Increased Target to $18 on, May 4th, 2020
David Amsellem of Piper Sandler, Maintained "Avadel Pharmaceuticals plc" (AVDL) at Buy with Increased Target from $14 to $18 on, May 4th, 2020.
David has made no other calls on AVDL in the last 4 months.
There are 3 other peers that have a rating on AVDL. Out of the 3 peers that are also analyzing AVDL, 0 agree with David's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with David
- Chris Howerton of "Jefferies" Initiated at Strong Buy and Held Target at $14 on, Friday, April 3rd, 2020
- Paul Matteis of "Stifel" Initiated at Strong Buy and Held Target at $14 on, Thursday, March 12th, 2020
- Francois Brisebois of "Craig-Hallum" Initiated at Strong Buy and Held Target at $15 on, Thursday, January 30th, 2020
Contributing Sources